- Featured News /
Novartis is one of 73 companies included in the 2017 Water A List by CDP, the nonprofit global environmental disclosure platform.
- Featured News /
RAND Corporation and the Moran Company issued reports discussing the cost savings associated with biosimilars.
- Featured News /
Leprosy is an ancient disease that currently infects more than 200 000 people each year. For more than three decades, Novartis and the Novartis Foundation has been working to reduce the incidence of leprosy, and the Novartis Foundation recently helped establish the Global Partnership for Zero Leprosy in an effort to eliminate the disease.
- Featured News /
For over 40 years Novartis has been committed to understanding sickle cell disease and working towards treatment.
- Featured News /
The third Novartis Social Business stakeholder dialogue took place on November 21 in Basel.
- Featured News /
Individualized CAR‑T therapy uses a patient’s own immune system to fight certain types of cancers.
- Featured News /
Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.
- Featured News /
Learn how we are shifting from making the patient fit the treatment to making the treatment fit the patient.
- Featured News /
Through a successful patient support program, Novartis is taking diabetes care beyond the pill in India.
- Featured News /
Learn how Novartis is working with chronic obstructive pulmonary disease (COPD) patients to develop digital health technologies that help them find their “new normal.”
Pagination
- ‹ Previous page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- …
- 20
- › Next page